Assuming thrice-weekly Copaxone entry in early 2014 and generic entry in Sep 2015, and not knowing pricing but don't think a big premium, I think a 20% switch is reasonable to expect.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.